Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 13, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 14, 2026
OfficerTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001225208-26-007811
Filed / recorded
Sep 14, 2026, 10:04 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Edwards Lifesciences Corp
Issuer CIK
1099800
Ticker
EW
Reporting person
Andrew M. Dahl
Relationship
Officer
Officer title
SVP, Corporate Controller
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Sep 13, 2026
Transaction code
F
Shares / units
253
Price per share
$84.37
Acquired / disposed
Disposed (D)
Shares owned after
14,615.41
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).